LIFECORE BIOMEDICAL, INC. Operating Lease, Payments, Use
LIFECORE BIOMEDICAL, INC. (LFCR) reported Operating Lease, Payments, Use of $94.00 thousand for the 9-month period ending 2020-02-23, per its 10-Q filed 2020-04-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePaymentsUse · last filed 2020-04-03
- LIFECORE BIOMEDICAL, INC. operating lease, payments, use for the quarter ending 2020-02-23 was $32.00K.
- LIFECORE BIOMEDICAL, INC. operating lease, payments, use for the quarter ending 2019-11-24 was $32.00K.
- LIFECORE BIOMEDICAL, INC. operating lease, payments, use for the quarter ending 2019-08-25 was $30.00K.
| Period end | Operating Lease, Payments, Use 3 month | Operating Lease, Payments, Use 6 month | Operating Lease, Payments, Use 9 month |
|---|---|---|---|
| 2020-02-23 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $64.00K derived: sum of 2 quarters · filed 2020-04-03 | $94.00K 10-Q · filed 2020-04-03 |
| 2019-11-24 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $62.00K 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $30.00K 10-Q · filed 2019-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |